Strategic Blueprint LLC Makes New Investment in Hinge Health Inc. $HNGE

Strategic Blueprint LLC acquired a new position in Hinge Health Inc. (NYSE:HNGE) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,692 shares of the company’s stock, valued at approximately $346,000.

Separately, CHURCHILL MANAGEMENT Corp purchased a new stake in shares of Hinge Health in the second quarter worth $828,000.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on HNGE shares. Canaccord Genuity Group increased their price objective on shares of Hinge Health from $52.00 to $61.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Morgan Stanley increased their price objective on shares of Hinge Health from $57.00 to $67.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 23rd. JMP Securities increased their price objective on shares of Hinge Health from $58.00 to $65.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. Needham & Company LLC increased their price objective on shares of Hinge Health from $47.00 to $59.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Finally, Robert W. Baird assumed coverage on shares of Hinge Health in a research report on Friday, September 5th. They set a “neutral” rating and a $56.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $57.47.

Hinge Health Price Performance

Shares of NYSE:HNGE opened at $49.52 on Monday. The stock’s fifty day moving average is $54.05. Hinge Health Inc. has a fifty-two week low of $33.42 and a fifty-two week high of $62.18.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, August 5th. The company reported ($13.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($4.98) by ($8.12). The company had revenue of $139.10 million for the quarter, compared to analysts’ expectations of $125.16 million. During the same period last year, the company posted ($0.96) EPS. The business’s revenue was up 54.9% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.